Literature DB >> 6906128

The development of the irido-corneal angle in the chick embryo.

G Renard, M Hirsch, M Savoldelli, Y Pouliquen.   

Abstract

The iridocorneal angle of the chick embryo was examined by scanning electron microscopy from the 7th day to the 19th day of development. The mesodermal tissue situated between the corneal endothelium and the iris differentiated into trabecular cells. These cells formed a strip on the 9th day and enlarged on the 13th day to form long cellular fibres. The trabecular meshwork was recognizable on the 15th day and reached full development only on the 19th day. The development of the trabecular meshwork was probably much earlier than is usually described. It began with differentiation of the corneal endothelial cells and these cells acquired a multipolar cell body with long cellular processes. The last stage is probably regulated to avoid an abnormal development of the angle structure. These results can be correlated with those obtained in the morphological examination of the structure of the angle in congenital glaucoma and the "cleavage syndrome" of the anterior chamber.

Entities:  

Mesh:

Year:  1980        PMID: 6906128     DOI: 10.1007/bf00410509

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  4 in total

1.  [Proceedings: the iridocorneal angle in congenital glaucoma, seen in the scanning microscope].

Authors:  F Hervouet; P Sourdille
Journal:  Bull Soc Ophtalmol Fr       Date:  1975-01

2.  Juvenile glaucoma associated with goniodysgenesis.

Authors:  M M Rodrigues; G L Spaeth; S Weinreb
Journal:  Am J Ophthalmol       Date:  1976-06       Impact factor: 5.258

3.  Scanning electron microscopic studies on the development of the iridocorneal angle in human eyes.

Authors:  H A Hansson; T Jerndal
Journal:  Invest Ophthalmol       Date:  1971-04

4.  [Some aspects of congenital glaucoma (author's transl)].

Authors:  S Lalive d'Epinay; C Remé
Journal:  Klin Monbl Augenheilkd       Date:  1977-02       Impact factor: 0.700

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.